2011
Extensive product development planning

Dr Stephen Page, a leading veterinary pharmacologist, with a successful background with big pharma, kick starts the pre-clinical studies of Luoda’s pipeline
2013
BioSA grant to support novel dairy unit experiment

Awarded $50,000 to support the development of experimental dairy at University of Adelaide’s Roseworthy Campus
JUN 2013
Australian Research Council (ARC) Linkage Grant

Grant worth over $500,000 to help find solutions to the issue of antibiotic resistance in animal health
NOV 2013
Patent application: Pimobendan Liquid Formulation

Examination phase of the international patent commences globally.
FEB 2014
Patent application: microbial infection treatments

Patent applications submitted to protect the use of ionophores for the treatment of mastitis in dairy cattle and skin infections in dogs
DEC 2014
Distribution & Development agreement signed

Major agreement with a Top 10 Global Pharmaceutical company for the commercialisation of an oral solution of the canine cardiac drug pimodendan
2011-15
Over $2m seed capital already invested in R&D

A recent second fund raise has put Luoda in a position where its current portfolio is fully-funded.
JULY 2015
Registration dossier submitted to APVMA

Pimobendan liquid formulation becomes Luoda’s first submission to APVMA for registered status
September 2016
Pimobendan oral solution approved by APVMA and sales as VETMEDIN ORAL SOLUTION commence soon afterwards.